• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有社区获得性肺炎且伴有或不伴有哮喘的儿童之间呼吸道微生物群的差异。

Differences of the respiratory microbiota between children suffering from community acquired pneumonia with presence or absence of asthma.

作者信息

Chen Lei, Chen Huan, Lv Tian, Guo Xiaolei, Wu Weiwei, Zhao Deyu, Liu Feng

机构信息

Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.

Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, China.

出版信息

Sci Rep. 2025 Jul 1;15(1):20458. doi: 10.1038/s41598-025-04847-y.

DOI:10.1038/s41598-025-04847-y
PMID:40593979
Abstract

Recent advancements in respiratory microbiota research have progressively elucidated their pivotal role in pediatric respiratory pathologies. Alterations in airway microbial communities are intricately associated with diverse respiratory conditions and distinct disease states. This study conducted a comparative analysis of respiratory microecological profiles in pediatric cohorts diagnosed with community-acquired pneumonia (CAP), stratified by the presence or absence of comorbid bronchial asthma, from whom nasopharyngeal aspirates were obtained for metagenomic next-generation sequencing (mNGS). Analyses revealed comparable alpha-diversity indices between groups; however, beta-diversity metrics demonstrated marked compositional divergence. In the asthma-CAP cohort, Streptococcus pneumoniae and Rothia mucilaginosa emerged as predominant taxa, whereas Mycoplasmoides pneumoniae and Trichoderma citrinoviride dominated microbial profiles in uncomplicated CAP patients.

摘要

呼吸微生物群研究的最新进展逐步阐明了它们在儿童呼吸道疾病中的关键作用。气道微生物群落的改变与多种呼吸道疾病和不同的疾病状态密切相关。本研究对诊断为社区获得性肺炎(CAP)的儿童队列的呼吸道微生态特征进行了比较分析,根据是否合并支气管哮喘进行分层,从这些儿童中获取鼻咽抽吸物进行宏基因组下一代测序(mNGS)。分析显示各组之间的α多样性指数相当;然而,β多样性指标显示出明显的组成差异。在哮喘合并CAP队列中,肺炎链球菌和黏液罗氏菌是主要的分类群,而在单纯CAP患者中,肺炎支原体和黄绿木霉在微生物谱中占主导地位。

相似文献

1
Differences of the respiratory microbiota between children suffering from community acquired pneumonia with presence or absence of asthma.患有社区获得性肺炎且伴有或不伴有哮喘的儿童之间呼吸道微生物群的差异。
Sci Rep. 2025 Jul 1;15(1):20458. doi: 10.1038/s41598-025-04847-y.
2
Clinical Features and Value of Tracheal Aspirate Metagenomic Next-Generation Sequencing for Severe Pneumonia in Children in Pediatric Intensive Care Unit.儿科重症监护病房中儿童重症肺炎气管吸出物宏基因组下一代测序的临床特征及价值
Pol J Microbiol. 2025 Jun 18;74(2):192-205. doi: 10.33073/pjm-2025-016. eCollection 2025 Jun 1.
3
The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: A systematic review.中国大陆 5 岁以下儿童社区获得性肺炎的病因:系统综述。
Hum Vaccin Immunother. 2017 Nov 2;13(11):2742-2750. doi: 10.1080/21645515.2017.1371381. Epub 2017 Sep 18.
4
Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.儿童和青少年社区获得性肺炎中肺炎支原体诊断的临床症状和体征
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD009175. doi: 10.1002/14651858.CD009175.pub2.
5
Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.阿莫西林为基础的治疗儿童社区获得性肺炎的短疗程与长疗程:系统评价和荟萃分析。
Eur J Pediatr. 2022 Nov;181(11):3795-3804. doi: 10.1007/s00431-022-04603-8. Epub 2022 Sep 6.
6
Signatures of lower respiratory tract microbiome in children with severe community-acquired pneumonia using shotgun metagenomic sequencing.利用鸟枪法宏基因组测序分析重症社区获得性肺炎患儿下呼吸道微生物组特征
J Microbiol Immunol Infect. 2025 Feb;58(1):86-93. doi: 10.1016/j.jmii.2024.11.011. Epub 2024 Nov 29.
7
Lower respiratory tract co-infection of and respiratory syncytial virus shapes microbial landscape and clinical outcomes in children.副流感病毒与呼吸道合胞病毒的下呼吸道合并感染塑造了儿童的微生物格局和临床结局。
Front Cell Infect Microbiol. 2025 Jun 9;15:1593053. doi: 10.3389/fcimb.2025.1593053. eCollection 2025.
8
Childhood necrotising pneumonia, empyema and complicated parapneumonic effusion secondary to community acquired pneumonia: report of 158 cases from a tertiary hospital in Egypt.儿童坏死性肺炎、脓胸及社区获得性肺炎继发的复杂性肺炎旁积液:埃及一家三级医院158例报告
Respir Res. 2025 Jul 2;26(1):235. doi: 10.1186/s12931-025-03291-w.
9
Clinical epidemiological characteristics of hospitalized pediatric viral community-acquired pneumonia in China.中国住院儿童病毒性社区获得性肺炎的临床流行病学特征
J Infect. 2025 Mar;90(3):106450. doi: 10.1016/j.jinf.2025.106450. Epub 2025 Feb 24.
10
Real-world efficacy and safety of cefepime for pediatric community-acquired pneumonia: a propensity score-matched study.头孢吡肟用于儿童社区获得性肺炎的真实世界疗效和安全性:一项倾向评分匹配研究。
Front Cell Infect Microbiol. 2025 Jun 18;15:1616184. doi: 10.3389/fcimb.2025.1616184. eCollection 2025.

本文引用的文献

1
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
2
Clinical analysis of the epidemiology and changes in inflammatory indexes of in acute and recovery stage pediatric patients.小儿患者急性和恢复期的流行病学及炎症指标变化的临床分析
Transl Pediatr. 2022 Oct;11(10):1645-1655. doi: 10.21037/tp-22-416.
3
Application of Metagenomic Next-Generation Sequencing (mNGS) Using Bronchoalveolar Lavage Fluid (BALF) in Diagnosing Pneumonia of Children.
宏基因组下一代测序(mNGS)在支气管肺泡灌洗液(BALF)检测儿童肺炎中的应用。
Microbiol Spectr. 2022 Oct 26;10(5):e0148822. doi: 10.1128/spectrum.01488-22. Epub 2022 Sep 28.
4
Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study.通过支气管肺泡灌洗液宏基因组下一代测序提高疑似肺部感染诊断:一项多中心回顾性研究。
Microbiol Spectr. 2022 Aug 31;10(4):e0247321. doi: 10.1128/spectrum.02473-21. Epub 2022 Aug 9.
5
Utility of Metagenomic Next-Generation Sequencing for Etiological Diagnosis of Patients with Sepsis in Intensive Care Units.宏基因组下一代测序在重症监护病房脓毒症患者病因诊断中的应用。
Microbiol Spectr. 2022 Aug 31;10(4):e0074622. doi: 10.1128/spectrum.00746-22. Epub 2022 Jul 21.
6
is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.是慢性肺病患者呼吸道中的一种抗炎细菌。
Eur Respir J. 2022 May 5;59(5). doi: 10.1183/13993003.01293-2021. Print 2022 May.
7
The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children.LncRNA NNT-AS1、CRP、PCT 及其相互作用与儿童难治性肺炎支原体肺炎的关系。
Sci Rep. 2021 Jan 21;11(1):2059. doi: 10.1038/s41598-021-81853-w.
8
Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids.宏基因组下一代测序快速检测感染性体液中的病原体。
Nat Med. 2021 Jan;27(1):115-124. doi: 10.1038/s41591-020-1105-z. Epub 2020 Nov 9.
9
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis.抗中性粒细胞胞质抗体相关性血管炎与结节病肺微生物组比较。
Sci Rep. 2020 Jun 11;10(1):9466. doi: 10.1038/s41598-020-66178-4.
10
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.宏基因组学揭示了与慢性呼吸道疾病相关的微生物群核心大环内酯类耐药组。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):433-447. doi: 10.1164/rccm.201911-2202OC.